Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación

Targeting Splicing in the Treatment of Human Disease

  • Suñé-Pou, Marc
  • Prieto-Sánchez, Silvia
  • Boyero-Corral, Sofía
  • Moreno-Castro, Cristina
  • El Yousfi, Younes
  • Suñé-Negre, Josep Mª
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
The tightly regulated process of precursor messenger RNA (pre-mRNA) alternative splicing (AS) is a key mechanism in the regulation of gene expression. Defects in this regulatory process affect cellular functions and are the cause of many human diseases. Recent advances in our understanding of splicing regulation have led to the development of new tools for manipulating splicing for therapeutic purposes. Several tools, including antisense oligonucleotides and <i>trans</i>-splicing, have been developed to target and alter splicing to correct misregulated gene expression or to modulate transcript isoform levels. At present, deregulated AS is recognized as an important area for therapeutic intervention. Here, we summarize the major hallmarks of the splicing process, the clinical implications that arise from alterations in this process, and the current tools that can be used to deliver, target, and correct deficiencies of this key pre-mRNA processing event., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to Carlos Suñé and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) and the Andalusian Government (Excellence Project CTS-6587) to Cristina Hernández-Munain Support from the European Region Development Fund (ERDF (FEDER)) is also acknowledged. We apologize to all researchers whose papers pertinent to this article we failed to cite, We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Notch Signaling Controls Transcription via the Recruitment of RUNX1 and MYB to Enhancers during T Cell Development

  • Rodríguez-Caparrós, Alonso
  • García-Altamirano, Vanina
  • Casal, Áurea
  • López-Ros, Jennifer
  • García-Mariscal, Alberto
  • Tani-ichi, Shizue
  • Ikuta, Koichi
  • Hernández-Munaín, Cristina
Tcrd and Tcrg display identical developmental programs that depend on the activity of the enhancers E delta and E gamma being "on" in pre-beta-selection thymocytes to activate transcription and V(D) J recombination of the unrearranged genes and "off" in post-beta-selection CD4(+)CD8(+) double-positive thymocytes to inhibit transcription of the rearranged genes and avoid the expression of TCR delta- and TCR gamma-chains in alpha beta T lymphocytes. E delta and E gamma activity depends on transcription factor binding to essential Runx and Myb sites and parallels that of Notch signaling. We performed Notch gain- and loss-of-function experiments and found that Notch signaling activates Tcrd and Tcrg transcription by favoring the recruitment of RUNX1 and MYB to the enhancers. Our results suggest that the dissociation of RUNX1 and MYB from E delta and E gamma chromatin in double-positive thymocytes, which results in enhancer inactivation, is caused by decreased Notch signaling triggered by pre-TCR signaling, thereby deciphering the molecular mechanism of Tcrd and Tcrg silencing during beta-selection. These findings reveal a novel molecular mechanism for gene regulation via Notch signaling through the recruitment of RUNX1 and MYB to enhancer chromatin during thymocyte development., This work was supported by research funding from the Spanish Government (BFU2016-79699P)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy

  • Suñé-Pou, Marc
  • Prieto-Sánchez, Silvia
  • El Yousfi, Younes
  • Boyero-Corral, Sofía
  • Nardi-Ricart, Anna
  • Nofrerias-Roig, Isaac
  • Pérez-Lozano, Pilar
  • García-Montoya, Encarna
  • Minarro-Carmona, Montserrat
  • Ramón Tico, Josep
  • Suñé-Negre, Josep Mª
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
Background: Cationic solid lipid nanoparticles (SLNs) have been given considerable attention for therapeutic nucleic acid delivery owing to their advantages over viral and other nanoparticle delivery systems. However, poor delivery efficiency and complex formulations hinder the clinical translation of SLNs. Aim: The aim of this study was to formulate and characterize SLNs incorporating the cholesterol derivative cholesteryl oleate to produce SLN-nucleic acid complexes with reduced cytotoxicity and more efficient cellular uptake. Methods: Five cholesteryl oleate-containing formulations were prepared. Laser diffraction and laser Doppler microelectrophoresis were used to evaluate particle size and zeta potential, respectively. Nanoparticle morphology was analyzed using electron microscopy. Cytotoxicity and cellular uptake of lipoplexes were evaluated using flow cytometry and fluorescence microscopy. The gene inhibition capacity of the lipoplexes was assessed using siRNAs to block constitutive luciferase expression. Results: We obtained nanoparticles with a mean diameter of approximately 150-200 nm in size and zeta potential values of 25-40 mV. SLN formulations with intermediate concentrations of cholesteryl oleate exhibited good stability and spherical structures with no aggregation. No cell toxicity of any reference SLN was observed. Finally, cellular uptake experiments with DNA- and RNA-SLNs were performed to select one reference with superior transient transfection efficiency that significantly decreased gene activity upon siRNA complexation. Conclusion: The results indicate that cholesteryl oleate-loaded SLNs are a safe and effective platform for nonviral nucleic acid delivery., We are grateful to many colleagues for their helpful suggestions, critical discussions, and comments. We thank Jose Alcami and Mayte Coiras (National Microbiology Center, Majadahonda, Madrid, Spain) for the TZM-bl cells. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to CS and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) to CHM. Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged. MSP was supported by a fellowship from the Spanish Ministry of Education (FPU Program [Training Program for Academic Staff])., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Targeting proteins to RNA transcription and processing sites within the nucleus, Conferencia: 1st International Caparica Conference in Splicing (SPLICING)

  • Sánchez-Hernández, Noemí
  • Prieto-Sánchez, Silvia
  • Moreno-Castro, Cristina
  • Muñoz-Cobo, Juan Pablo
  • El Yousfi, Younes
  • Boyero-Corral, Sofía
  • Suñé-Pou, Marc
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
Conferencia: 1st International Caparica Conference in Splicing (SPLICING) Ubicación: Lisbon, PORTUGAL Fecha: SEP 12-14, 2016 Patrocinador(es):BRUKER; Elsevier; ThermoFisher Sci; RNA Soc; STAB Vida, Studies of the spatial organization of the highly compartmentalized eukaryotic nucleus and dynamics of transcription and RNA processing within it are fundamental for fully understanding how gene expression is regulated in the cell. Although some progress has been made in deciphering the functional consequences of this complex network of interacting molecules in the context of nuclear organization, how proteins and RNA move in the nucleus and how the transcription and RNA processing machineries find their targets are important questions that remain largely unexplored. Here, we review major hallmarks and novel insights regarding the movement of RNA and proteins in the context of nuclear organization as well as the mechanisms by which the proteins involved in RNA processing localize to specific nuclear compartments., We are grateful to many colleagues for their helpful suggestions, critical discussions, and comments. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project B10-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) to C.H.M. Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged. We apologize to all researchers with papers pertinent to this article whose work we failed to cite., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Improved synthesis and characterization of cholesteryl oleate-loaded cationic solid lipid nanoparticles with high transfection efficiency for gene therapy applications

  • Suñé-Pou, Marc
  • Limeres, María J.
  • Nofrerias, Isaac
  • Nardi-Ricart, Anna
  • Prieto-Sánchez, Silvia
  • El Yousfi, Younes
  • Pérez-Lozano, Pilar
  • García-Montoya, Encarna
  • Minarro-Carmona, Montserrat
  • Ramón Tico, Josep
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
  • Suñé-Negre, Josep Mª
The development of new nanoparticle formulations that are capable of high transfection efficiency without toxicity is essential to provide new tools for gene therapy. However, the issues of complex, poorly reproducible manufacturing methods, and low efficiencies during in vivo testing have prevented translation to the clinic. We have previously reported the use of cholesteryl oleate as a novel excipient for solid lipid nanoparticles (SLNs) for the development of highly efficient and nontoxic nucleic acid delivery carriers. Here, we performed an extensive characterization of this novel formulation to make the scale up under Good Manufacturing Practice (GMP) possible. We also describe the complete physicochemical and biological characterization of cholesteryl oleate-loaded SLNs to ensure the reproducibility of this formula and the preservation of its characteristics before and after the lyophilization process. We defined the best manufacturing method and studied the influence of some parameters on the obtained nanoparticles using the Quality by Design (ICH Q8) guideline to obtain cholesteryl oleate-loaded SLNs that remain stable during storage and guarantee in vitro nucleic acid delivery efficacy. Our results indicate that this improved formulation is suitable for gene therapy with the possibility of scale-up the manufacturing of nanoparticles under GMP conditions., We are grateful to many colleagues for their helpful suggestions, critical discussions, and comments. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2017-89179-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) to C.H.M. Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged. M.S.-P. was supported by a fellowship from the Spanish Ministry of Education (FPU Program)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role for the splicing factor TCERG1 in Cajal body integrity and snRNP assembly

  • Moreno-Castro, Cristina
  • Prieto-Sánchez, Silvia
  • Sánchez-Hernández, Noemí
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
Este artículo ha sido seleccionado para su inclusión en la sección “Research Highlights” de la revista., Cajal bodies are nuclear organelles involved in the nuclear phase ofsmall nuclear ribonucleoprotein (snRNP) biogenesis. In this study, weidentified the splicing factor TCERG1 as a coilin-associated factorthat is essential for Cajal body integrity. Knockdown of TCERG1disrupts the localization of the components of Cajal bodies, includingcoilin and NOLC1, with coilin being dispersed in the nucleoplasm intonumerous small foci, without affecting speckles, gems or the histonelocus body. Furthermore, the depletion of TCERG1 affects therecruitment of Sm proteins to uridine-rich small nuclear RNAs(snRNAs) to form the mature core snRNP. Taken together, theresults of this study suggest that TCERG1 plays an important role inCajal body formation and snRNP biogenesis., This work was supported by grants from the Spanish Ministry of Economy andCompetitiveness (Ministerio de Economı́a y Competitividad; grant numberBFU2017-89179-R to C.S. and grant number BFU2016-79699-P to C.H.M.) and theAndalusian Government (Excellence Project BIO-2515/2012) to C.S. Support fromthe European Region Development Fund [ERDF (FEDER)] is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Drosophila Prp40 localizes to the histone locus body and regulates gene transcription and development

  • Prieto-Sánchez, Silvia
  • Moreno-Castro, Cristina
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
In eukaryotes, a large amount of histones need to be synthesized during the S phase of the cell cycle to package newly synthesized DNA into chromatin. The transcription and 3' end processing of histone pre-mRNAs are controlled by the histone locus body (HLB), which is assembled on the shared promoter for H3 and H4 Here, we identified the Drosophila Prp40 pre-mRNA processing factor (dPrp40, annotated as CG3542) as a novel HLB component. We showed that dPrp40 is essential for Drosophila development, with functionally conserved activity in vertebrates and invertebrates. We observed that dPrp40 is fundamental in endocycling cells, highlighting a role for this factor in mediating replication efficiency in vivo The depletion of dPrp40 from fly cells inhibited the transcription, but not the 3' end processing, of histone mRNA in a H3- and H4-promoter-dependent manner. Our results establish that dPrp40 is an essential protein for Drosophila development that can localize to the HLB and might participate in histone mRNA biosynthesis., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad; BFU2014-54660-R and BFU2017-89179-R) and the Andalusian Government (BIO-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (BFU2016-79699-P) to C.H.M. S.P.-S. was supported by a contract from the Spanish Ministry of Economy and Competitiveness (Juan de la Cierva Program). Support from the European Region Development Fund [ERDF (FEDER)] is also acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease

  • Suñé-Pou, Marc
  • Limeres, M.J.
  • Moreno-Castro, Cristina
  • Hernández-Munaín, Cristina
  • Suñé-Negre, Josep Mª
  • Cuestas, María L.
  • Suñé, Carlos
Alternative splicing of pre-mRNA contributes strongly to the diversity of cell- and tissue-specific protein expression patterns. Global transcriptome analyses have suggested that >90% of human multiexon genes are alternatively spliced. Alterations in the splicing process cause missplicing events that lead to genetic diseases and pathologies, including various neurological disorders, cancers, and muscular dystrophies. In recent decades, research has helped to elucidate the mechanisms regulating alternative splicing and, in some cases, to reveal how dysregulation of these mechanisms leads to disease. The resulting knowledge has enabled the design of novel therapeutic strategies for correction of splicing-derived pathologies. In this review, we focus primarily on therapeutic approaches targeting splicing, and we highlight nanotechnology-based gene delivery applications that address the challenges and barriers facing nucleic acid-based therapeutics., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2017-89179-R to CS and grant number BFU2016-79699-P to CH-M). Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged.